Literature DB >> 21750400

Prevalence of cardiovascular risk factors in male and female patients with primary hyperparathyroidism.

D Han1, S Trooskin, X Wang.   

Abstract

OBJECTIVE: To investigate the prevalence of cardiovascular risk factors in patients with primary hyperparathyroidism (PHPT) and to determine if they are gender specific.
METHODS: This was a retrospective case control study. Three hundred and sixty-three men and women with PHPT and 363 age-, sex-, and body mass index (BMI)-matched controls with benign goiter were included in the study. We documented each patient's laboratory results along with the presence of any cardiovascular risk factors. Intra-operatively, the resected parathyroid adenomas were weighed and recorded. The data are expressed as the number of patients in each category and percentage of total patients in that group and the mean±SD.
RESULTS: The prevalence of obesity, hypertension, hyperlipidemia, Type 2 diabetes, and coronary artery disease (CAD) is higher in PHPT patients compared to the general New Jersey population and age-, sex-, and BMI-matched goiter patients. Male PHPT patients tended to be more obese and were found to have heavier parathyroid adenomas compared to female patients (p<0.05). Additionally, a higher percentage of male PHPT patients were found to have higher rates of CAD (11.5%) and Type 2 diabetes (23.0%) compared to female patients (5.80% and 10.9%, respectively, p<0.05).
CONCLUSIONS: There is a higher prevalence of metabolic disorders and CAD in PHPT patients. Male PHPT patients had larger parathyroid adenomas at the time of surgery and had a higher prevalence of obesity, Type 2 diabetes and CAD compared to female PHPT patients.

Entities:  

Mesh:

Year:  2011        PMID: 21750400     DOI: 10.3275/7861

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  30 in total

Review 1.  The role of estrogens and related compounds in the management of primary hyperparathyroidism.

Authors:  Robert Marcus
Journal:  J Bone Miner Res       Date:  2002-11       Impact factor: 6.741

2.  Gender, health, and physician visits among adults in the United States.

Authors:  K Tom Xu; Tyrone F Borders
Journal:  Am J Public Health       Date:  2003-07       Impact factor: 9.308

3.  Changes in insulin sensitivity and glucose and bone metabolism over time in patients with asymptomatic primary hyperparathyroidism.

Authors:  Semra Ayturk; Alptekin Gursoy; Neslihan Bascil Tutuncu; Derun Taner Ertugrul; Nilgun Guvener Demirag
Journal:  J Clin Endocrinol Metab       Date:  2006-08-08       Impact factor: 5.958

4.  Raloxifene lowers serum calcium and markers of bone turnover in postmenopausal women with primary hyperparathyroidism.

Authors:  Mishaela R Rubin; Kristen H Lee; Donald J McMahon; Shonni J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2003-03       Impact factor: 5.958

5.  A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery.

Authors:  S J Silverberg; E Shane; T P Jacobs; E Siris; J P Bilezikian
Journal:  N Engl J Med       Date:  1999-10-21       Impact factor: 91.245

6.  Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism.

Authors:  Jens Bollerslev; Thord Rosen; Charlotte L Mollerup; Jörgen Nordenström; Marek Baranowski; Celina Franco; Ylva Pernow; Gunhild A Isaksen; Kristin Godang; Thor Ueland; Svante Jansson
Journal:  J Clin Endocrinol Metab       Date:  2009-04-07       Impact factor: 5.958

7.  Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism.

Authors:  C Y Guo; W E Thomas; A W al-Dehaimi; A M Assiri; R Eastell
Journal:  J Clin Endocrinol Metab       Date:  1996-10       Impact factor: 5.958

8.  Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial.

Authors:  Jens Bollerslev; Svante Jansson; Charlotte L Mollerup; Jörgen Nordenström; Eva Lundgren; Ove Tørring; Jan-Erik Varhaug; Marek Baranowski; Sylvi Aanderud; Celina Franco; Bo Freyschuss; Gunhild A Isaksen; Thor Ueland; Thord Rosen
Journal:  J Clin Endocrinol Metab       Date:  2007-02-06       Impact factor: 5.958

9.  Prevalence of type 2 diabetes mellitus in patients with primary hyperparathyroidism.

Authors:  Monica G Cardenas; Karen J Vigil; Gary B Talpos; Min W Lee; Edward Peterson; D Sudhaker Rao
Journal:  Endocr Pract       Date:  2008 Jan-Feb       Impact factor: 3.443

10.  Disturbances of calcium homeostasis consistent with mild primary hyperparathyroidism in premenopausal women and associated morbidity.

Authors:  Helene Siilin; Jonas Rastad; Osten Ljunggren; Ewa Lundgren
Journal:  J Clin Endocrinol Metab       Date:  2007-11-27       Impact factor: 5.958

View more
  13 in total

1.  Evaluation of left ventricle functions by tissue Doppler, strain, and strain rate echocardiography in patients with primary hyperparathyroidism.

Authors:  Didem Ozdemir; Gulhan Yuksel Kalkan; Nihal Akar Bayram; Eda Demir Onal; Reyhan Ersoy; Engin Bozkurt; Bekir Cakir
Journal:  Endocrine       Date:  2014-03-28       Impact factor: 3.633

2.  Cardiovascular risk and metabolic syndrome in primary hyperparathyroidism and their correlation to different clinical forms.

Authors:  M Procopio; M Barale; S Bertaina; S Sigrist; R Mazzetti; M Loiacono; G Mengozzi; E Ghigo; M Maccario
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

Review 3.  Nontraditional manifestations of primary hyperparathyroidism.

Authors:  Marcella Donovan Walker; Mishaela Rubin; Shonni J Silverberg
Journal:  J Clin Densitom       Date:  2013 Jan-Mar       Impact factor: 2.617

Review 4.  Primary hyperparathyroidism and hypertension.

Authors:  Sarah B Fisher; Nancy D Perrier
Journal:  Gland Surg       Date:  2020-02

5.  High prevalence of metabolic syndrome in a mestizo group of adult patients with primary hyperparathyroidism (PHPT).

Authors:  Victoria Mendoza-Zubieta; Gloria A Gonzalez-Villaseñor; Guadalupe Vargas-Ortega; Baldomero Gonzalez; Claudia Ramirez-Renteria; Moises Mercado; Mario A Molina-Ayala; Aldo Ferreira-Hermosillo
Journal:  BMC Endocr Disord       Date:  2015-04-03       Impact factor: 2.763

6.  The Value of the Model and Quantitative Parameters of Contrast-Enhanced Ultrasound in Judging the Severity of SHPT.

Authors:  Xing-Xin Liang; Fan Li; Feng Gao; Yang Liu; Xiao-Hui Qiao; Zheng Zhang; Lian-Fang Du
Journal:  Biomed Res Int       Date:  2016-12-19       Impact factor: 3.411

7.  The Effect of Hyperparathyroid State on Platelet Functions and Bone Loss.

Authors:  Göknur Yorulmaz; Aysen Akalın; Olga Meltem Akay; Garip Şahin; Cengiz Bal
Journal:  Turk J Haematol       Date:  2015-08-06       Impact factor: 1.831

8.  Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism.

Authors:  Selvihan Beysel; Mustafa Caliskan; Muhammed Kizilgul; Mahmut Apaydin; Seyfullah Kan; Mustafa Ozbek; Erman Cakal
Journal:  BMC Cardiovasc Disord       Date:  2019-05-08       Impact factor: 2.298

9.  Symptoms of Primary Hyperparathyroidism in Men and Women: The Same but Different?

Authors:  Theresia Weber; Andreas Hillenbrand; Simon Peth; Rainer Hummel
Journal:  Visc Med       Date:  2020-01-22

10.  Comparison of Initial Clinical Presentations between Primary Hyperparathyroidism Patients from New Brunswick and Changsha.

Authors:  Lingqiong Meng; Shuying Liu; Aseel Al-Dayyeni; Zhifeng Sheng; Zhiguang Zhou; Xiangbing Wang
Journal:  Int J Endocrinol       Date:  2018-09-18       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.